OLIPASS CORPORATION |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 481 KRW | +2.12% |
|
-0.21% | -37.86% |
| 18/03 | OLIPASS Corporation announced that it has received KRW 3.5 billion in funding | CI |
| 06/03 | OLIPASS Corporation announced that it expects to receive KRW 5 billion in funding | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OLIPASS CORPORATION | Bio Therapeutic Drugs | +2.12% | -0.21% | -37.86% | -76.99% | - | 1.22Cr | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- A244460 Stock
- Charts OLIPASS Corporation
- Comparison Chart
